Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
CPIXCumberland Pharmaceuticals Inc
| Figure | CPIXCumberland Pharmaceuticals IncFY2025 · Dec |
|---|---|
| Revenue | $44.52M |
| Revenue, yoy | +17.6% |
| Net income | $2.84M |
| Net income, yoy | +56.2% |
| Net margin | -6.4% |
| Free cash flow | $4.83M |
| FCF margin | 10.9% |
| EPS, diluted | $0.19 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed